Strader Doris B, Bacon Bruce R, Lindsay Karen L, La Brecque Douglas R, Morgan Timothy, Wright Elizabeth C, Allen Jeff, Khokar M Farooq, Hoofnagle Jay H, Seeff Leonard B
Division of Gastroenterology, Hepatology and Nutrition, Veterans Affairs Medical Center, Washington, DC 20422, USA.
Am J Gastroenterol. 2002 Sep;97(9):2391-7. doi: 10.1111/j.1572-0241.2002.05993.x.
Complementary and alternative medicine (CAM) is used by 42% of the U.S. population. Its use among patients with chronic liver disease has not been well defined. Toward that end, we surveyed patients in six geographically diverse liver disease clinics in the United States for use of CAM.
Patients attending six liver disease clinics were polled via a common questionnaire regarding their use of CAM. Demographic information was obtained to identify predictors of CAM use. Statistical analysis included univariate and multivariate analysis using logistic regression.
A total of 989 patients completed the questionnaire. Of these, 389 (39%) admitted to using some form of CAM at least once during the preceding month; 21% admitted to using herbal preparations, and 13% used herbs to treat their liver disease. Five variables were found to be predictive of alternative therapy use: female sex, young age, level of education, annual income, and geographic location. In all, 74% of patients reported using CAM in addition to the medications prescribed by their physician, but 26% did not inform their physician of their CAM use.
CAM use is as common among patients visiting liver disease clinics in the United States as in the general population (39% vs 42%). Many patients are using herbs to treat their liver disease but are declining to discuss this use with their physician.
42%的美国人口使用补充和替代医学（CAM）。其在慢性肝病患者中的使用情况尚未明确界定。为此，我们对美国六个地理位置不同的肝病诊所的患者使用CAM的情况进行了调查。
通过一份通用问卷对六个肝病诊所的患者进行调查，询问他们对CAM的使用情况。收集人口统计学信息以确定使用CAM的预测因素。统计分析包括使用逻辑回归的单变量和多变量分析。
共有989名患者完成了问卷。其中，389名（39%）承认在前一个月至少使用过某种形式的CAM；21%承认使用过草药制剂，13%使用草药治疗肝病。发现有五个变量可预测替代疗法的使用：女性、年轻、教育程度、年收入和地理位置。总体而言，74%的患者报告除了服用医生开的药物外还使用CAM，但26%的患者未告知医生他们使用CAM的情况。
在美国，肝病诊所患者使用CAM的情况与普通人群相同（39%对42%）。许多患者使用草药治疗肝病，但不愿与医生讨论这种使用情况。
